Amag Pharmaceuticals Inc (AMAG) Return on Assets ROA from the third quarter of 2020 to third quarter of 2019 and for the year 2020, Average High and Low, Fundamental Ratios from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amag Pharmaceuticals inc   (NASDAQ: AMAG)


Amag Pharmaceuticals Inc 's ROA from the third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Amag Pharmaceuticals Inc 's ROA in the third quarter of 2020?
Amag Pharmaceuticals Inc recorded a cumulative net loss of $-181 million during 12 months ending in the third quarter of 2020, resulting in a negative return on assets (ROA) of -24.11%.

However, within the Healthcare sector 373 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2020 quarter, so far to 3749, from total ROA ranking in the second quarter of 2020 at 3851.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Total Assets Change -24.03 % -30.14 % -29.76 % -32.67 % -20.5 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -181 -223 -344 -466 -289
Return On Assets (TTM) -24.11 % -27.7 % -38.97 % -48.4 % -27.28 %
AMAG's Total Ranking # 3749 # 3851 # 4093 # 4723 # 3965
Total Assets (TTM) in million 734 716 754 791 967
Seq. Total Assets Change 2.63 % -5.05 % -4.76 % -18.14 % -5.62 %
Seq. Net Income Change 11994.38 % - - - -

AMAG's 5 Years Annual ROA >> Back to AMAG Management Effectiveness >> Compare AMAG ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 130
Sector # 374
Overall # 3627

Return On Assets Statistics
High Average Low
19.86 %
-9.57 %
-48.4 %
(Dec 31 2014)   (Dec 31 2019)





Financial Statements
Amag Pharmaceuticals Inc 's Assets $ 734 million AMAG's Balance sheet
Amag Pharmaceuticals Inc 's Income $ 19 million Quarterly AMAG's Income Statement
AMAG's Income by Division See AMAG's Income by Division



Annual Return On Assets (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016		 (Dec 31 2015)
FY 2015
Y / Y Total Assets Change -32.69 % -36.57 % -25.23 % -0.36 % 79.09 %
Total Assets in million 791 1,175 1,853 2,478 2,487
Y / Y Net Income Change - - - - -75.87 %
Net Income in million -468 -66 -199 -2 33
Annual Return On Assets -59.11 % -5.59 % -10.75 % -0.1 % 1.32 %

AMAG's 5 Years Annual ROA >> Back to AMAG Management Effectiveness >> Compare AMAG ROA to its Competitors



More Return On Assets Ratios
AMAG's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
AMAG's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for AMAG's Competitors
Subscribers only: Roa for Amag Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for AMAG's Customers

You may also want to know
AMAG's Roi AMAG's Inventory Turnover Ratio AMAG's Growth Rates AMAG's Dividend Comparisons
AMAG's Profitability Ratios AMAG's Asset Turnover Ratio AMAG's Dividend Growth
AMAG's Roe AMAG's Valuation Ratios AMAG's Financial Strength Ratios AMAG's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2020, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:04+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.